Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4111451000168111 | Trajentamet 2.5 mg/850 mg (linagliptin 2.5 mg + metformin hydrochloride 850 mg) tablet, 28 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4111461000168113 | Trajentamet 2.5 mg/850 mg tablet, 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trajentamet 2.5 mg/850 mg tablet, 28 | Is a | linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet, 28 | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/850 mg tablet, 28 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/850 mg tablet, 28 | has TPUU | Trajentamet 2.5 mg/850 mg tablet | true | Inferred relationship | Some | 1 | |
| Trajentamet 2.5 mg/850 mg tablet, 28 | has TP | Trajentamet 2.5 mg/850 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trajentamet 2.5 mg/850 mg tablet, 28, blister pack | Is a | True | Trajentamet 2.5 mg/850 mg tablet, 28 | Inferred relationship | Some |
Reference Sets
Unit of use quantity reference set
Description inactivation indicator reference set
Trade product pack reference set
FHIR